Clinical Trial Update: EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating hydroxychloroquine plus azithromycin for prevention of COVID-19–related ARDS was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Hydroxychloroquine-azithromycin combination

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Sars-CoV-2, Community-Acquired Pneumonia,COVID-19 | Phase 3 | Status: WITHDRAWN